Empire Life Investments Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Empire Life Investments Inc.
- $1.54 Billion
- Q4 2024
A detailed history of Empire Life Investments Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Empire Life Investments Inc. holds 279,463 shares of ARCT stock, worth $4.71 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
279,463
Previous 150,692
85.45%
Holding current value
$4.71 Million
Previous $3.5 Million
35.6%
% of portfolio
0.31%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding ARCT
# of Institutions
177Shares Held
25.4MCall Options Held
195KPut Options Held
133K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$79 Million0.25% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$44.6 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$39 Million0.62% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$35.4 Million0.46% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$34.8 Million0.02% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $448M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...